216 related articles for article (PubMed ID: 27481043)
1. Role of
Elkhatib AH; Soldatova L; Carrau RL; Hachem RA; Ditzel L; Campbell R; Prevedello DM; Prevedello L; Filho LF; Campbell RG
Laryngoscope; 2017 Feb; 127(2):321-324. PubMed ID: 27481043
[TBL] [Abstract][Full Text] [Related]
2. Utility of FDG PET/CT in the Characterization of Sinonasal Neoplasms: Analysis of Standardized Uptake Value Parameters.
Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
AJR Am J Roentgenol; 2018 Dec; 211(6):1354-1360. PubMed ID: 30300005
[TBL] [Abstract][Full Text] [Related]
3. Relationship between
Felix-Ravelo M; Bey A; Arous F; Paris-Grandpierre S; Jankowski R; Nguyen DT
Acta Otolaryngol; 2017 Feb; 137(2):191-195. PubMed ID: 27576899
[TBL] [Abstract][Full Text] [Related]
4. The added value of 18F-FDG PET/CT for evaluation of patients with esthesioneuroblastoma.
Broski SM; Hunt CH; Johnson GB; Subramaniam RM; Peller PJ
J Nucl Med; 2012 Aug; 53(8):1200-6. PubMed ID: 22728262
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of tumoral heterogeneity and volumetric parameters as measured by F18-FDG PET/CT in sinonasal cancer.
Kim BS; Pak K; Yi KI; Kim IJ; Roh HJ; Cho KS
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1437-1443. PubMed ID: 27747383
[TBL] [Abstract][Full Text] [Related]
6. The feasibility of 18F-fluorodeoxyglucose-positron emission tomography uptake as a prognostic factor for paranasal sinus malignancy.
Seol JH; Kim J; Lee JD; Lee JG; Yoon JH; Kim CH
Am J Rhinol Allergy; 2013; 27(2):118-22. PubMed ID: 23562200
[TBL] [Abstract][Full Text] [Related]
7. High 18F-FDG Avidity of Low-Grade Esthesioneuroblastoma.
Jannin A; Turpin A; Baillet C; Aubert S; Do Cao C
Clin Nucl Med; 2018 Mar; 43(3):e101-e102. PubMed ID: 29293141
[TBL] [Abstract][Full Text] [Related]
8. Preliminary study on the evaluation of olfactory neuroblastoma using PET/CT.
Wu HB; Wang QS; Zhong JM; Zhou WL; Li HS; Qiao-yu W
Clin Nucl Med; 2011 Oct; 36(10):894-8. PubMed ID: 21892040
[TBL] [Abstract][Full Text] [Related]
9. Does sophisticated diagnostic workup on neuroectodermal tumors have an impact on the treatment of esthesioneuroblastoma?
Haas I; Ganzer U
Onkologie; 2003 Jun; 26(3):261-7. PubMed ID: 12845211
[TBL] [Abstract][Full Text] [Related]
10. Performance of whole-body
Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):847-855. PubMed ID: 30604061
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up using 18F-FDG PET/CT for postoperative olfactory neuroblastoma.
Fujioka T; Toriihara A; Kubota K; Machida Y; Nakamura S; Kishimoto S; Ohashi I; Shibuya H
Nucl Med Commun; 2014 Aug; 35(8):857-63. PubMed ID: 24751700
[TBL] [Abstract][Full Text] [Related]
12. The cytologic features of sinonasal undifferentiated carcinoma and olfactory neuroblastoma.
Bellizzi AM; Bourne TD; Mills SE; Stelow EB
Am J Clin Pathol; 2008 Mar; 129(3):367-76. PubMed ID: 18285258
[TBL] [Abstract][Full Text] [Related]
13. 68Ga-DOTATATE and 18F-FDG PET/CT for the Management of Esthesioneuroblastoma of the Sphenoclival Region.
Dadgar H; Norouzbeigi N; Ahmadzadehfar H; Assadi M
Clin Nucl Med; 2020 Aug; 45(8):e363-e364. PubMed ID: 32558717
[TBL] [Abstract][Full Text] [Related]
14. Appropriate timing of surveillance intervals with whole-body
Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
Eur J Radiol; 2019 Sep; 118():75-80. PubMed ID: 31439262
[TBL] [Abstract][Full Text] [Related]
15. Prediction of survival with combining quantitative
Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
Head Neck; 2019 Sep; 41(9):3080-3089. PubMed ID: 31041831
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic study of sinonasal teratocarcinosarcoma and its contrast with olfactory neuroblastoma].
Li X; Liu HG; Xie XJ; Han YD; Li M
Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):458-64. PubMed ID: 19035117
[TBL] [Abstract][Full Text] [Related]
17. A case of olfactory neuroblastoma detected by (18)F-FDG PET/CT.
Tanaka K; Yamamoto Y; Hoshikawa H; Nishiyama Y
Clin Nucl Med; 2014 Jul; 39(7):635-6. PubMed ID: 24662664
[TBL] [Abstract][Full Text] [Related]
18. [Sinonasal undifferentiated carcinoma. A rare and aggressive neoplasm of the nasal cavity and paranasal sinuses].
Reichel O; Ihrler S; Born F; Andratschke M; Rasp G; Hagedorn H
HNO; 2006 May; 54(5):394-6, 398-9. PubMed ID: 16034634
[TBL] [Abstract][Full Text] [Related]
19. Sinonasal undifferentiated carcinoma: clinical and pathologic features and a discussion on classification, cellular differentiation, and differential diagnosis.
Ejaz A; Wenig BM
Adv Anat Pathol; 2005 May; 12(3):134-43. PubMed ID: 15900114
[TBL] [Abstract][Full Text] [Related]
20. Positron emission computed tomography and magnetic resonance imaging features of sinonasal small round blue cell tumors.
Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
Neuroradiol J; 2020 Feb; 33(1):48-56. PubMed ID: 31460836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
